Cart summary

You have no items in your shopping cart.

Pramipexole 2HCl Monohydrate

SKU: orb1222570

Description

Pramipexole Dihydrochloride is a D2/3 agonist. It acts by reducing mitochondrial ROS production and inhibiting the activation of apoptotic pathways.(In Vitro):Pramipexole dihydrochloride hydrate shows a low binding affinity for D1-type receptor, with an IC50 of >50,000 nM.Pramipexole dihydrochloride hydrate (0.01-10 μM; 72 hours) produces dose-dependent increases of dendritic arborization and soma size.Pramipexole dihydrochloride hydrate attenuates levodopa-induced toxicity in mesencephalic cultures.(In Vivo):Pramipexole dihydrochloride hydrate (0.25-1 mg/kg; i.p.) significantly reduces the infarction volume in animals.Pramipexole dihydrochloride hydrate improves neurological recovery.Pramipexole dihydrochloride hydrate prevents ischemic cell death via mitochondrial pathways in ischemic stroke.

Images & Validation

Key Properties

CAS Number191217-81-9
MW302.26
Purity>98% (HPLC)
FormulaC10H17N3S·2HCl·H2O
SMILESO.Cl.CCCN[C@H]1CCc2c(C1)sc(N)n2.Cl
TargetD2S|D2L|D3|D4
SolubilityIn Vitro: H2O : 100 mg/mL (330.84 mM)

Bioactivity

In Vivo
Pramipexole dihydrochloride hydrate (0.25-1 mg/kg; i.p.) significantly reduces the infarction volume in animals. Pramipexole dihydrochloride hydrate improves neurological recovery. Pramipexole dihydrochloride hydrate prevents ischemic cell death via mitochondrial pathways in ischemic stroke. Animal model: Male Wistar rats weighing 250-300 g (16-18 weeks old). Dosage: 0.25 mg/kg, 1 mg/kg. Administration: Intraperitoneal injection. Result: Decreased infarction volume as compared to tMCAO (transient middle cerebral artery occlusion)-only animals.
In Vitro
Pramipexole dihydrochloride hydrate shows a low binding affinity for D1-type receptor, with an IC50 of >50, 000 nM. Pramipexole dihydrochloride hydrate (0.01-10 μM; 72 hours) produces dose-dependent increases of dendritic arborization and soma size. Pramipexole dihydrochloride hydrate attenuates levodopa-induced toxicity in mesencephalic cultures.

Storage & Handling

StorageStorage temperature: -20°C. Stability: ≥ 2 years
Expiration Date12 months from date of receipt.
DisclaimerFor research use only

Alternative Names

Pramipexole Dihydrochloride Monohydrate | Pramipexole Dihydrochloride

Similar Products

  • Pramipexole dihydrochloride hydrate [orb1300317]

    99.68%

    191217-81-9

    302.26

    C10H17N3S·2HCl·H2O

    10 mg, 50 mg, 100 mg, 200 mg, 500 mg, 1 ml x 10 mM (in DMSO), 25 mg
Quality Guarantee

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

Documents Download

Datasheet
Product Information
Download

Request a Document

Protocol Information

Pramipexole 2HCl Monohydrate (orb1222570)

  • Star
  • Star
  • Star
  • Star
  • Star
  • 0.0
Based on 0 reviews

Participating in our Biorbyt product reviews program enables you to support fellow scientists by sharing your firsthand experience with our products.

Login to Submit a Review

No reviews yet

Step 1: Enter information below

(Recommended: An additional animal making an allowance for loss during the experiment)

Step 2: Enter the in vivo formulation

(This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO +
%+
% Tween 80 +
%

Available Sizes

Select a size below

500 mg
10 mg
$ 80.00
25 mg
$ 120.00
50 mg
$ 190.00
100 mg
$ 260.00
200 mg
$ 370.00